Tower Research Capital LLC (TRC) - ARCA BIOPHARMA INC ownership

ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 25 filers reported holding ARCA BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 8.52 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ARCA BIOPHARMA INC
ValueSharesWeighting
Q3 2023$7,419
+49.7%
3,691
+51.1%
0.00%
Q2 2023$4,957
+82516.7%
2,442
-18.4%
0.00%
Q1 2023$6
+100.0%
2,991
+103.2%
0.00%
Q4 2022$3
-99.7%
1,472
+182.0%
0.00%
Q3 2022$1,000
-90.9%
522
-89.5%
0.00%
Q1 2022$11,000
+120.0%
4,951
+116.7%
0.00%
Q4 2021$5,000
-28.6%
2,285
-2.4%
0.00%
Q3 2021$7,0002,341
+3292.8%
0.00%
Q2 2021$0
-100.0%
69
-99.6%
0.00%
-100.0%
Q1 2021$57,000
+5600.0%
15,660
+9749.1%
0.00%
Q3 2020$1,000159
+15800.0%
0.00%
Q4 2019$010.00%
Other shareholders
ARCA BIOPHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
BML Capital Management, LLC 706,930$1,406,7911.22%
Newtyn Management, LLC 519,765$1,034,3320.20%
Murchinson Ltd. 52,800$100,6800.01%
Marquette Asset Management, LLC 17,318$34,4630.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 46,948$93,4270.00%
Tekla Capital Management LLC 32,461$64,5970.00%
OSAIC HOLDINGS, INC. 57$1130.00%
DIMENSIONAL FUND ADVISORS LP 42,502$84,5790.00%
Parallel Advisors, LLC 244$4860.00%
BANK OF AMERICA CORP /DE/ 31$620.00%
View complete list of ARCA BIOPHARMA INC shareholders